In vitro quality parameters of whole blood‐derived platelets pooled using two different platelet pooling sets and stored up to 7 days are similar
Transfusion · 2024
DOI: 10.1111/trf.17591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Tania Vandenbroeke und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research & Development, Terumo BCT, Inc., Lakewood, Colorado, USA. Hauptthemen laut MEDLINE: Blood Platelets, Platelet-Rich Plasma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Terumo BCT.
Abstract (Originalsprache)
Background
Increasing the number of collections of whole blood‐derived platelets (WBDP) and lengthening the allowable storage time may alleviate platelet (PLT) shortages. There is a need for new PLT pooling sets that can provide acceptable quality on Day 7 of storage. Study Design and Methods This pool‐and‐split study compared WBDP prepared using the platelet‐rich plasma method with the novel IMUGARD WB PLT pooling set and a control pooling set. After pooling and filtration, PLT products were tested on Days 1, 5, and 7. Large volume delayed sampling (LVDS) cultures were taken on Day 2.
Results
The median postfiltration residual white blood cell (rWBC) content was 0.18 million per product (maximum 1.26 million; n = 69) with mean PLT recovery of 88.5 ± 2.8% for the new set and median 0.23 million (maximum 1.83 million) rWBC with 87.5 ± 2.5% recovery for the control. Day 5 mean pH 22°C were 7.18 ± 0.12 and 7.13 ± 0.10 for the new and control set, respectively. Day 5 in vitro quality parameters were within 20% between the two pooling sets. The new set Day 7 pH 22°C was acceptable (7.07 ± 0.17, 100% ≥ 6.3), and most parameters were within 20% of Day 5 values.
Conclusion
WBDP quality for the new pooling set is acceptable across a battery of in vitro tests when stored up to 7 days and meets FDA regulatory criteria. The quality parameters were similar between the new pooling set and the control set on Day 5. This new set is compatible with LVDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research & Development, Terumo BCT, Inc., Lakewood, Colorado, USA.
- Vitalant Research Institute, Vitalant, Denver, Colorado, USA.
- Administrative and Components Divisions, South Texas Blood & Tissue, San Antonio, Texas, USA.
- Department of Medical Services, Carter BloodCare, Bedford, Texas, USA.
- Hoxworth Blood Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado, USA.
ORCID-Profile: Tania Vandenbroeke, Frances Compton, Larry J Dumont
Förderung
- NHLBI NIH HHS
- Terumo BCT
Zitieren
APA
Vandenbroeke, T., Gloor, C., Wingfield, T., Leite, C., Carr, K., Turner, C., Ngamsuntikul, S., Sutor, L., Compton, F., Nestheide, S., Rugg, N., Cancelas, J. A., & Dumont, L. J. (2024). In vitro quality parameters of whole blood‐derived platelets pooled using two different platelet pooling sets and stored up to 7 days are similar. Transfusion. https://doi.org/10.1111/trf.17591
Vancouver
Vandenbroeke T, Gloor C, Wingfield T, Leite C, Carr K, Turner C, et al. In vitro quality parameters of whole blood‐derived platelets pooled using two different platelet pooling sets and stored up to 7 days are similar. Transfusion. 2024. doi:10.1111/trf.17591
BibTeX
@article{Vandenbroeke2024,
author = {Vandenbroeke, Tania and Gloor, Christina and Wingfield, Tyler and Leite, Caroline and Carr, Kathlynn and Turner, Chris and Ngamsuntikul, Samantha and Sutor, Laurie and Compton, Frances and Nestheide, Shawnagay and Rugg, Neeta and Cancelas, Jose A and Dumont, Larry J},
title = {In vitro quality parameters of whole blood‐derived platelets pooled using two different platelet pooling sets and stored up to 7 days are similar},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.17591}
}
EUVIMED